(14724821), H. D., (4246156), L. T., (22047845), M. H. H., (14724824), T. S. S., (17380453), S. M. Y., (1474849), H. M. K., . . . (9236533), Z. H. M. (2024). Inhibition of cytochrome P450 epoxygenase promotes endothelium-to-mesenchymal transition and exacerbates doxorubicin-induced cardiovascular toxicity.
Chicago Style (17th ed.) Citation(14724821), Hevna Dhulkifle, Lubna Therachiyil (4246156), Maram H. Hasan (22047845), Tahseen S. Sayed (14724824), Shahd M. Younis (17380453), Hesham M. Korashy (1474849), Huseyin C. Yalcin (6695099), and Zaid H. Maayah (9236533). Inhibition of Cytochrome P450 Epoxygenase Promotes Endothelium-to-mesenchymal Transition and Exacerbates Doxorubicin-induced Cardiovascular Toxicity. 2024.
MLA (9th ed.) Citation(14724821), Hevna Dhulkifle, et al. Inhibition of Cytochrome P450 Epoxygenase Promotes Endothelium-to-mesenchymal Transition and Exacerbates Doxorubicin-induced Cardiovascular Toxicity. 2024.